Skip to main content

A key part of Biden's plan to combat Covid is at risk as FDA meets to debate booster shots

A key FDA panel meets Friday to debate and vote at around 2:30 p.m. ET on Pfizer and BioNTech's application to offer booster shots to the general public.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.